PPAR-α also negatively regulated acute phase response signaling pathways and proinflammatory reaction, as demonstrated in rodent models of NAFLD, atherosclerosis, systemic inflammation, and nonalcoholic steatohepatitis [15, 16]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.